BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 38829467)

  • 1. Unraveling the Mechanisms of Cannabidiol's Pharmacological Actions: A Comprehensive Research Overview.
    Kalsoom I; Shehzadi K; Li HS; Wen HL; Yu MJ
    Top Curr Chem (Cham); 2024 Jun; 382(2):20. PubMed ID: 38829467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
    Scuderi C; Filippis DD; Iuvone T; Blasio A; Steardo A; Esposito G
    Phytother Res; 2009 May; 23(5):597-602. PubMed ID: 18844286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials.
    Silvestro S; Mammana S; Cavalli E; Bramanti P; Mazzon E
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31013866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Standardized
    Mabou Tagne A; Marino F; Legnaro M; Luini A; Pacchetti B; Cosentino M
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects.
    Mechoulam R; Hanus L
    Chem Phys Lipids; 2002 Dec; 121(1-2):35-43. PubMed ID: 12505688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances of cannabidiol studies in medicinal chemistry, pharmacology and therapeutics.
    Thakkar K; Ruan CH; Ruan KH
    Future Med Chem; 2021 Nov; 13(22):1935-1937. PubMed ID: 34583522
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects.
    Breuer A; Haj CG; Fogaça MV; Gomes FV; Silva NR; Pedrazzi JF; Del Bel EA; Hallak JC; Crippa JA; Zuardi AW; Mechoulam R; Guimarães FS
    PLoS One; 2016; 11(7):e0158779. PubMed ID: 27416026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD).
    Peng J; Fan M; An C; Ni F; Huang W; Luo J
    Basic Clin Pharmacol Toxicol; 2022 Apr; 130(4):439-456. PubMed ID: 35083862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constituents of Cannabis Sativa.
    Rock EM; Parker LA
    Adv Exp Med Biol; 2021; 1264():1-13. PubMed ID: 33332000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular basis for the anti-inflammatory and anti-fibrosis properties of cannabidiol.
    Sunda F; Arowolo A
    FASEB J; 2020 Nov; 34(11):14083-14092. PubMed ID: 32885502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
    Romano B; Borrelli F; Pagano E; Cascio MG; Pertwee RG; Izzo AA
    Phytomedicine; 2014 Apr; 21(5):631-9. PubMed ID: 24373545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors.
    Zanelati TV; Biojone C; Moreira FA; Guimarães FS; Joca SR
    Br J Pharmacol; 2010 Jan; 159(1):122-8. PubMed ID: 20002102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol: an overview of some pharmacological aspects.
    Mechoulam R; Parker LA; Gallily R
    J Clin Pharmacol; 2002 Nov; 42(S1):11S-19S. PubMed ID: 12412831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol, a Regulator of Intracellular Calcium and Calpain.
    Jeon KH; Park SH; Bae WJ; Kim SW; Park HJ; Kim S; Kim TH; Jeon SH; Park I; Park HJ; Kwon Y
    Cannabis Cannabinoid Res; 2023 Feb; 8(1):119-125. PubMed ID: 35196129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis sativa: Much more beyond Δ
    Alves P; Amaral C; Teixeira N; Correia-da-Silva G
    Pharmacol Res; 2020 Jul; 157():104822. PubMed ID: 32335286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discovery.
    Del Pozo A; Barker-Haliski M
    Exp Neurol; 2023 Feb; 360():114288. PubMed ID: 36471511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.
    Zuardi AW; Crippa JA; Hallak JE; Moreira FA; Guimarães FS
    Braz J Med Biol Res; 2006 Apr; 39(4):421-9. PubMed ID: 16612464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and side effects of cannabidiol, a Cannabis sativa constituent.
    Bergamaschi MM; Queiroz RH; Zuardi AW; Crippa JA
    Curr Drug Saf; 2011 Sep; 6(4):237-49. PubMed ID: 22129319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders.
    Campos AC; Moreira FA; Gomes FV; Del Bel EA; Guimarães FS
    Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3364-78. PubMed ID: 23108553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
    Fasinu PS; Phillips S; ElSohly MA; Walker LA
    Pharmacotherapy; 2016 Jul; 36(7):781-96. PubMed ID: 27285147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.